Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
Researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the management of chronic migraine.
Treatments
Solutions for Hyperhidrosis: Newly Approved Treatments and Research Update
Newly approved treatment options for axillary hyperhidrosis give more opportunities for clinicians to provide personalized treatment for patients.
Triple Combo Regimens May Address Cause of Cystic Fibrosis
Promising results for VX-659-, VX-445-tezacaftor-ivacaftor for cystic fibrosis with mutations in CFTR.
Olaparib Treatment May Improve Health-Related Quality of Life in Germline BRCA1/2-Mutated Ovarian Cancer
Olaparib, may help to improve duration of good quality of life and quality-adjusted progression-free survival in germline BRCA1/2-mutated ovarian cancer.
Fostamatinib Seems Effective for Immune Thrombocytopenia
Overall response of platelet count 50,000/L seen in 43% of patients.
Gut Microbiota Alterations May Not Be Enough to Relieve Irritable Bowel Syndrome
As fecal microbiota transplantation has been found to be effective in treating a number of gastrointestinal diseases, such as Clostridium difficile infection, researchers are now assessing whether it may also be effective for patients with irritable bowel syndrome.
TMS Device Cleared to Treat Obsessive Compulsive Disorder
Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.
Ibalizumab Active in Multidrug Resistant HIV-1 Infection
Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.
Antibiotics Often Unnecessary for Sacral Pressure Ulcers Complicated by Osteomyelitis
A systematic literature review, published in Clinical Infectious Diseases, found no evidence supporting a benefit to antibacterial therapy for osteomyelitis in patients with stage IV sacral pressure ulcers.
Daily BCX7353 Cuts Rate of Hereditary Angioedema Attacks
Oral administration of BCX7353 at dose of 125 mg results in lower rate of attacks vs placebo.
Next post in Allergy and Immunology Information Center
